Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
STA Pharmaceutical
STA Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Manufacturing Chemist Live: Day One Review
The first day of MC Live has now concluded, with attendees enjoying presentations from STA Pharmaceuticals, NSF International and Lonza, among others
Manufacturing
Process optimisation with biocatalysis
From route scouting, screening and scale-up to commercial production, Dr Jingyang Zhu, VP Process Chemistry Enabling Technologies at WuXi, discusses the services and capabilities of a modern CDMO
Manufacturing
Process optimisation with flow chemistry
WuXi STA, the Chinese CDMO with a global footprint, embraces the need to develop drugs for customers using safer, more cost-effective technologies and expedite their time to market
Drug Delivery
BioLingus partnership boosts WuXi STA’s solid dose potential
The collaboration will use BioLingus' technology to focus on sublingual and buccal drug delivery
Subscribe now